FLT4 and breast carcinoma: Also, a clinicopathological significance of VEGF-C and Flt-4 in breast cancer has been described, since their expression correlated with lymph node metastasis and decreased survival of patients (Kinoshita et al, 2001; Nakamura et al, 2003).